Ignyta

Personalized medicine for cancer and autoimmune diseases

placeSan Diego, California, United States calendar_todayFounded 2011 groups30 employees language ignyta.com

Registered entities

Innovation

24 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 3,813 times.

YearFilings
20145
201510
201612
201714
201816
201913
20209
20217
20226
20233
20241
20261

Investor mix

8 investors on record; lead investors include City Hill Ventures, Colt Ventures; 4 have since exited.

Investor typeCountShare
Venture capital338%
Private equity450%
Other / undisclosed113%
Coming soon